We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases MAPP on Transferring Ownership of Drug Applications
FDA Releases MAPP on Transferring Ownership of Drug Applications
The FDA has detailed how the agency’s Office of Generic Drugs (OGD) will handle requests for drug application ownership transfers in a new manual of policies and procedures (MAPP).